LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraine.
Sang CN, Ramadan NM, Wallihan RG, Chappell AS, Freitag FG, Smith TR, Silberstein SD, Johnson KW, Phebus LA, Bleakman D, Ornstein PL, Arnold B, Tepper SJ, Vandenhende F.
Sang CN, et al.
Cephalalgia. 2004 Jul;24(7):596-602. doi: 10.1111/j.1468-2982.2004.00723.x.
Cephalalgia. 2004.
PMID: 15196302
Clinical Trial.